Skip to content

PharmaEstica Manufacturing OÜ

Registry code (registrikood) 10264929Private limited company (Osaühing)VAT EE100541508Activity (EMTAK 21201): Ravimpreparaatide tootmineActive

Viimsi vald, Harju County · Financial data: annual reports up to 2025; tax data up to 2026 Q3

Revenue (2025)
€1.7M
▲ 14.9% vs 2024
Profit before tax (2025)
-€219k
Employees, FTE (2025)
25
State taxes paid, last 4 quarters
€277k

Revenue, profit and employees, 2019–2025

€235k2019€563k2020€772k2021€831k2022€728k2023€1.5M2024€1.7M2025
YearRevenue (müügitulu)Operating profit (ärikasum)Net profitEquity (omakapital)Employees, FTE
2019€234,658-€1,778,372€2,505,223€1,983,14330
2020€563,049-€1,639,878-€1,752,777€252,39034
2021€772,244-€1,168,275-€1,372,918-€1,120,52832
2022€830,528-€1,319,196-€1,623,296-€2,743,82427
2023€728,423-€775,302-€1,071,673-€3,815,49725
2024€1,517,157-€430,412-€527,604-€829,12925
2025€1,742,556-€111,322-€219,100-€1,048,22925

Balance sheet summary

YearCashTotal assetsCurrent liabilitiesNon-current liabilitiesEquity
2019€872€3,226,966€1,243,823—€1,983,143
2020€120,287€3,281,893€3,029,503—€252,390
2021€46,829€2,922,620€4,043,148—-€1,120,528
2022€14,238€2,700,600€5,444,424—-€2,743,824
2023€22,027€2,449,555€2,625,052€3,640,000-€3,815,497
2024€8,717€2,256,458€2,065,587€1,020,000-€829,129
2025€20,873€1,954,063€2,952,292€50,000-€1,048,229

Calculated ratios

Net profit margin = net profit ÷ revenue. Equity ratio = equity ÷ total assets. Seedata sources & methodology for how each figure is derived.

Quarterly tax and turnover data (EMTA)

QuarterState taxes paidWage taxesTurnoverEmployees
2022 Q1€57,154€61,281€41,10026
2022 Q2€67,254€70,032€209,95927
2022 Q3€75,013€79,033€315,56727
2022 Q4€67,364€70,020€423,66428
2023 Q1€54,363€57,733€219,45826
2023 Q2€86,063€88,652€174,89726
2023 Q3€83,784€88,170€169,98923
2023 Q4€66,124€69,116€271,86025
2024 Q1€56,533€60,039€310,93225
2024 Q2€90,864€94,293€815,45826
2024 Q3€78,238€82,473€334,21224
2024 Q4€33,719€34,749€413,84825
2025 Q1€61,009€64,324€524,99526
2025 Q2€81,550€86,005€379,86923
2025 Q3€52,567€53,984€301,82823
2025 Q4€93,271€97,397€594,38624
2026 Q1€23,224€24,172€465,62117
2026 Q2€83,462€86,498€503,50216
2026 Q3€77,518€76,990€318,39416

Source: EMTA quarterly published data, as of 10 October 2026. Covers state taxes and wage taxes actually paid and turnover and employee counts as declared by the company, not the annual report figures above.

About this data

In the 2025 financial year (period 1 January 2025–31 December 2025), PharmaEstica Manufacturing OÜ reported revenue of €1,742,556.

The company recorded a net loss of €219,100 in the 2025 financial year.

Revenue increased by 14.9% from €1,517,157 in 2024 to €1,742,556 in 2025.

Revenue grew at a compound annual rate of 39.7% between 2019 and 2025.

Equity accounted for -53.6% of total assets of €1,954,063 at the end of the 2025 reporting period.

With 25 full-time-equivalent employees in 2025, revenue per employee was €69,702.

Across the 4 most recent quarters declared to EMTA, up to Q3 2026, PharmaEstica Manufacturing OÜ reported €1,881,903 in turnover.

EMTA recorded 16 employees for the quarter ending Q3 2026, compared with 25 full-time-equivalent employees in the 2025 annual report.

Browse

Source

Source: Estonian e-Business Register open data (Centre of Registers and Information Systems, RIK), licence CC BY-SA 4.0, modified; Estonian Tax and Customs Board (EMTA) quarterly data. Downloaded 2026-11-16. This is not an official register extract — see ariregister.rik.ee.

Company data on this site is available under CC BY-SA 4.0.

To request a correction or the removal of this page, use the contact form. Removal requests are handled within 30 days, no justification required.